Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42,218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparative evaluation of bioequivalence of Gan & Lee glargine U300 and Toujeo® in Chinese healthy male participants.
Li X, He A, Liu B, Shan R, Zhu J, Li X, Xie T, Li Y, Chen M, Su H, Zhang C, Li L, Cheng D, Chen J, Wang Y, Su Y, Xu Y, Li Z, Zhou H, Chen W, Liu Y. Li X, et al. Among authors: zhu j. Front Endocrinol (Lausanne). 2024 Aug 7;15:1407829. doi: 10.3389/fendo.2024.1407829. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39170740 Free PMC article. Clinical Trial.
A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers.
Zhou H, Cao S, Zhu X, Xie J, Fan L, Ge Q, Wang Y, Zhu J, Liu Y, Shao Z, Shan R, Liu B, Wang H, Ding L. Zhou H, et al. Among authors: zhu x, zhu j. Expert Opin Drug Metab Toxicol. 2020 Oct;16(10):997-1003. doi: 10.1080/17425255.2020.1807935. Epub 2020 Aug 26. Expert Opin Drug Metab Toxicol. 2020. PMID: 32847423 Free article. Clinical Trial.
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects.
Xie J, Fan X, Su Y, Zhou H, Cao S, Zhu X, Zhu M, He C, Wang Y, Fan L, Ge Q, Zhu J, Liu B, Chen X, Xie Y, Ma L, Liu Y, Chen J, Wang H, Li Z. Xie J, et al. Among authors: zhu x, zhu j, zhu m. Clin Pharmacol Drug Dev. 2022 Nov;11(11):1273-1283. doi: 10.1002/cpdd.1136. Epub 2022 Jul 17. Clin Pharmacol Drug Dev. 2022. PMID: 35844038 Free PMC article. Clinical Trial.
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [14C] SHC014748M in healthy Chinese subjects following oral administration.
Guo F, Liu B, Li X, Wang H, Zhu X, Su Y, He C, Zhu M, Ding J, Xu Y, Zhao X, Wang Y, Shan R, Zhu J, Xie J, Ge Q, Fan L, Ding Y, Xie Y, Zhang C, Li H, Wang H, Zhou H. Guo F, et al. Among authors: zhu x, zhu j, zhu m. Cancer Chemother Pharmacol. 2023 Feb;91(2):143-156. doi: 10.1007/s00280-022-04493-5. Epub 2022 Dec 27. Cancer Chemother Pharmacol. 2023. PMID: 36572783
Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study.
Luo S, Qiu XM, Zeng XJ, Zhang DY, Wan B, Li X, Tian RH, Wang JT, Wang MY, Zhu J, Zhang C, Yang R, Chen F, Liang Y, Fan B, Jiang HJ, Wang XM, Chen W, Xu K, Gao JB, Du C, Zhang LN, Yang Y, Jia SJ, Ren H, Zu ZY, Xu PP, Zhong J, Yang YT, Zhou CS, Zhang W, Liu XX, Zhang QR, Xia F, Qi L, Lu MJ, Zhang LJ, Liu YX, Lu GM. Luo S, et al. Among authors: zhu j. Chin J Acad Radiol. 2022;5(1):20-28. doi: 10.1007/s42058-021-00072-4. Epub 2021 Jun 28. Chin J Acad Radiol. 2022. PMID: 34222797 Free PMC article.
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
Xu PP, Tian RH, Luo S, Zu ZY, Fan B, Wang XM, Xu K, Wang JT, Zhu J, Shi JC, Chen F, Wan B, Yan ZH, Wang RP, Chen W, Fan WH, Zhang C, Lu MJ, Sun ZY, Zhou CS, Zhang LN, Xia F, Qi L, Zhang W, Zhong J, Liu XX, Zhang QR, Lu GM, Zhang LJ. Xu PP, et al. Among authors: zhu j. Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020. Theranostics. 2020. PMID: 32483458 Free PMC article.
42,218 results
You have reached the last available page of results. Please see the User Guide for more information.